Initial Investigation of [18F]P17-059 in Parkinson's Disease Patients and Healthy Volunteers
Status:
Not yet recruiting
Trial end date:
2023-03-01
Target enrollment:
Participant gender:
Summary
This study investigates the initial safety profile of [18F]P17-059 in healthy volunteers
including dosimetry determination, and compares regional brain uptake and kinetics of
[18F]P17-059 in Parkinson's disease patients with regional brain uptake and kinetics of
[18F]P17-059 in healthy volunteers.